260 related articles for article (PubMed ID: 29346435)
21. Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain.
Raymond DD; Stewart SM; Lee J; Ferdman J; Bajic G; Do KT; Ernandes MJ; Suphaphiphat P; Settembre EC; Dormitzer PR; Del Giudice G; Finco O; Kang TH; Ippolito GC; Georgiou G; Kepler TB; Haynes BF; Moody MA; Liao HX; Schmidt AG; Harrison SC
Nat Med; 2016 Dec; 22(12):1465-1469. PubMed ID: 27820604
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanism of the enhanced viral fitness contributed by secondary mutations in the hemagglutinin protein of oseltamivir resistant H1N1 influenza viruses: modeling studies of antibody and receptor binding.
Behera AK; Basu S; Cherian SS
Gene; 2015 Feb; 557(1):19-27. PubMed ID: 25479009
[TBL] [Abstract][Full Text] [Related]
23. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
[TBL] [Abstract][Full Text] [Related]
24. Complete mapping of viral escape from neutralizing antibodies.
Doud MB; Hensley SE; Bloom JD
PLoS Pathog; 2017 Mar; 13(3):e1006271. PubMed ID: 28288189
[TBL] [Abstract][Full Text] [Related]
25. Improving Statistical Certainty of Glycosylation Similarity between Influenza A Virus Variants Using Data-Independent Acquisition Mass Spectrometry.
Chang D; Klein J; Hackett WE; Nalehua MR; Wan XF; Zaia J
Mol Cell Proteomics; 2022 Nov; 21(11):100412. PubMed ID: 36103992
[TBL] [Abstract][Full Text] [Related]
26. Toward animal cell culture-based influenza vaccine design: viral hemagglutinin N-glycosylation markedly impacts immunogenicity.
Hütter J; Rödig JV; Höper D; Seeberger PH; Reichl U; Rapp E; Lepenies B
J Immunol; 2013 Jan; 190(1):220-30. PubMed ID: 23225881
[TBL] [Abstract][Full Text] [Related]
27. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin.
Igarashi M; Ito K; Kida H; Takada A
Virology; 2008 Jul; 376(2):323-9. PubMed ID: 18456302
[TBL] [Abstract][Full Text] [Related]
28. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.
DeDiego ML; Anderson CS; Yang H; Holden-Wiltse J; Fitzgerald T; Treanor JJ; Topham DJ
Immunology; 2016 Jun; 148(2):160-73. PubMed ID: 26854888
[TBL] [Abstract][Full Text] [Related]
29. A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.
Wu NC; Wilson IA
J Mol Biol; 2017 Aug; 429(17):2694-2709. PubMed ID: 28648617
[TBL] [Abstract][Full Text] [Related]
30. Influenza A surface glycosylation and vaccine design.
Wu CY; Lin CW; Tsai TI; Lee CD; Chuang HY; Chen JB; Tsai MH; Chen BR; Lo PW; Liu CP; Shivatare VS; Wong CH
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):280-285. PubMed ID: 28028222
[TBL] [Abstract][Full Text] [Related]
31. Selection and antigenic characterization of immune-escape mutants of H7N2 low pathogenic avian influenza virus using homologous polyclonal sera.
Sitaras I; Spackman E; de Jong MCM; Parris DJ
Virus Res; 2020 Dec; 290():198188. PubMed ID: 33045306
[TBL] [Abstract][Full Text] [Related]
32. Impact of cultivation conditions on N-glycosylation of influenza virus a hemagglutinin produced in MDCK cell culture.
Rödig JV; Rapp E; Bohne J; Kampe M; Kaffka H; Bock A; Genzel Y; Reichl U
Biotechnol Bioeng; 2013 Jun; 110(6):1691-703. PubMed ID: 23297157
[TBL] [Abstract][Full Text] [Related]
33. Comparison of N-linked glycosylation on hemagglutinins derived from chicken embryos and MDCK cells: a case of the production of a trivalent seasonal influenza vaccine.
Li J; Liu S; Gao Y; Tian S; Yang Y; Ma N
Appl Microbiol Biotechnol; 2021 May; 105(9):3559-3572. PubMed ID: 33937925
[TBL] [Abstract][Full Text] [Related]
34. Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.
Kirchenbaum GA; Carter DM; Ross TM
J Virol; 2016 Jan; 90(2):1116-28. PubMed ID: 26559834
[TBL] [Abstract][Full Text] [Related]
35. Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans.
Sun W; Kang DS; Zheng A; Liu STH; Broecker F; Simon V; Krammer F; Palese P
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381487
[TBL] [Abstract][Full Text] [Related]
36. A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.
Wen F; Li L; Zhao N; Chiang MJ; Xie H; Cooley J; Webby R; Wang PG; Wan XF
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118117
[TBL] [Abstract][Full Text] [Related]
37. Specific sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype influenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice.
Tate MD; Brooks AG; Reading PC
J Immunol; 2011 Aug; 187(4):1884-94. PubMed ID: 21768397
[TBL] [Abstract][Full Text] [Related]
38. The Influenza B Virus Hemagglutinin Head Domain Is Less Tolerant to Transposon Mutagenesis than That of the Influenza A Virus.
Fulton BO; Sun W; Heaton NS; Palese P
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899093
[TBL] [Abstract][Full Text] [Related]
39. Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope.
Bajic G; Maron MJ; Adachi Y; Onodera T; McCarthy KR; McGee CE; Sempowski GD; Takahashi Y; Kelsoe G; Kuraoka M; Schmidt AG
Cell Host Microbe; 2019 Jun; 25(6):827-835.e6. PubMed ID: 31104946
[TBL] [Abstract][Full Text] [Related]
40. Antigenic sites of H1N1 influenza virus hemagglutinin revealed by natural isolates and inhibition assays.
Huang JW; Lin WF; Yang JM
Vaccine; 2012 Sep; 30(44):6327-37. PubMed ID: 22885274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
